Clinical Trial

Study of the Metabolism and Excretion of Zidebactam (WCK 5107) Following a Single Intravenous Infusion.

Completed Phase 1
View on ClinicalTrials.gov →
Summary
A Phase 1, Open-label Study of the Metabolism and Excretion of Zidebactam (WCK 5107) Following a Single Intravenous Infusion in Healthy Male Subjects
Protocol Amendment History 1 amendment
This ClinicalTrials.gov record has been amended once since 2025-11-20.
Trial Details
NCT Number NCT07247942
Lead Sponsor Wockhardt
Collaborators: Covance
Conditions Healthy Subjects (HS)
Enrollment 8 participants
Start Date 2017-12-13
Primary Completion 2018-01-20 (estimated)
Study Completion 2019-01-30 (estimated)
Updated on ClinicalTrials.gov 2026-02-18